Holly Horhey

DNP Doctor of Nursing Practice,  Cleveland Clinic 

Location: United States

Consulting Services

Sales and Marketing Research Consulting Hospital-Pharmacy-Insurance Scientific Writing

Areas Of Interest

Venovenous Hemodialysis, Continuous Interaction, Hydrophobic Laws, International Diet Modification lambda-Immunoglobulin Light Chain Valgus, Coxa CYP 2E1 Breast Neoplasms, Right-Sided lambda-Chains, Immunoglobulin DH 581 Therapies, Inhalation MEN-2A Syndromes Infection, Histoplasma RNAse H, HIV Cyclooxygenase-2 Inhibitors Hemodiafiltration, Intermittent Veno-Venous Reoviridae Muir Torre Syndrome Murine hepatitis virus FGFR2 Protein Injuries, Pulmonary Cortex, Secondary Motor Y-Linked Traits Frank Breech Presentation Manatee, Brazilian Dilminal Ileal Pouches Pathway, JNK Signaling Dolipol Immunoglobulin Light Chains Tumors, Island Cell Sodium Channel, Voltage-Gated, Type IV, alpha 1 Subunit Frontal Sinusitis Sensitivity, Tooth

Professional Narrative

Dr. Holly Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Amgen 2012
Executive Director, Harvard Med 2011

Education

Director Medicine, Baylor College 1996
Director Medicine, Harvard Medical School 1987

Referees

Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02